Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1984 May;60(703):328–335. doi: 10.1136/pgmj.60.703.328

Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature.

I M Spitz, M Sheinfeld, B Glasser, H J Hirsch
PMCID: PMC2417872  PMID: 6429655

Abstract

A patient with inappropriate thyrotrophin (TSH) secretion is described. She initially presented with classical hyperthyroidism during pregnancy, responded to propylthiouracil and, subsequently, had a normal delivery. Hyperthyroidism persisted and 7.5 months later a subtotal thyroidectomy was performed. After a further 16 months, mild symptoms of hyperthyroidism recurred. She again responded to propylthiouracil, but developed galactorrhoea. At that stage, it was noted that she had persistently elevated circulating TSH in the presence of elevated T4 and T3 levels. Her symptomatology was mild, although objective indices of thyroid activity, including pulse rate, BMR, sex hormone binding globulin and cholesterol, were indicative of hyperthyroidism. CT scan and tomography of the sella were normal. She had a markedly exaggerated TSH response to thyrotrophin releasing hormone (TRH). Basal TSH and responsiveness to TRH was suppressed by high dose dexamethasone. The TSH response to TRH was partially suppressed by exogenous T3, but there was no effect on basal TSH levels. TSH also decreased slightly with L-dopa and bromocriptine. Circulating TSH rose markedly during methimazole administration. TSH alpha and beta subunits were elevated and appropriate for the high TSH. In addition, both subunits increased following TRH. The patient had basal hyperprolactinaemia with an impaired prolactin (PRL) response to TRH and metoclopramide. PRL suppressed with L-dopa and bromocriptine. The remaining anterior pituitary function was intact. Most of the laboratory findings argue against the presence of a TSH producing pituitary tumour and the most likely cause for inappropriate TSH secretion in this patient is selective resistance of the thyrotroph to thyroid hormones. A mild element of peripheral resistance might also be present. The hyperprolactinaemia could be related to lactotroph resistance to thyroid hormone. The complexities of treatment in this patient are stressed. Therapy was initially attempted with low dose dexamethasone, but this had no effect. T3 treatment produced an exacerbation of her symptomatology and did not influence basal TSH, thyroid hormones, or 131I uptake. Bromocriptine administration for 11 months partially suppressed basal TSH without influencing T3 and there was an increase in T4. Methimazole did decrease her T4 and T3, but TSH and PRL rose to even greater levels. Her hyperthyroidism was eventually controlled with an ablative dose of 131I. Thyroid hormone will be given in an attempt to suppress her TSH.

Full text

PDF
328

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baylis P. H. Case of hyperthyroidism due to a chromophobe adenoma. Clin Endocrinol (Oxf) 1976 Mar;5(2):145–150. doi: 10.1111/j.1365-2265.1976.tb02825.x. [DOI] [PubMed] [Google Scholar]
  2. Benoit R., Pearson-Murphy B. E., Robert F., Marcovitz S., Hardy J., Tsoukas G., Gardiner R. J. Hyperthyroidism due to a pituitary TSH secreting tumour with amenorrhoea-galactorrhoea. Clin Endocrinol (Oxf) 1980 Jan;12(1):11–19. doi: 10.1111/j.1365-2265.1980.tb03127.x. [DOI] [PubMed] [Google Scholar]
  3. Bode H. H., Danon M., Weintraub B. D., Maloof F., Crawford J. D. Partial target organ resistance to thyroid hormone. J Clin Invest. 1973 Apr;52(4):776–782. doi: 10.1172/JCI107240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brooks M. H., Barbato A. L., Collins S., Garbincius J., Neidballa R. G., Hoffman D. Familial thyroid hormone resistance. Am J Med. 1981 Sep;71(3):414–421. doi: 10.1016/0002-9343(81)90169-8. [DOI] [PubMed] [Google Scholar]
  5. Cooper D. S., Ladenson P. W., Nisula B. C., Dunn J. F., Chapman E. M., Ridgway E. C. Familial thyroid hormone resistance. Metabolism. 1982 May;31(5):504–509. doi: 10.1016/0026-0495(82)90242-6. [DOI] [PubMed] [Google Scholar]
  6. Duello T. M., Halmi N. S. Pituitary adenoma producing thyrotropin and prolactin. An immunocytochemical and electron microscopic study. Virchows Arch A Pathol Anat Histol. 1977 Nov 25;376(3):255–265. doi: 10.1007/BF00432401. [DOI] [PubMed] [Google Scholar]
  7. Elewaut A., Mussche M., Vermeulen A. Familial partial target organ resistance to thyroid hormones. J Clin Endocrinol Metab. 1976 Sep;43(3):575–581. doi: 10.1210/jcem-43-3-575. [DOI] [PubMed] [Google Scholar]
  8. Emerson C. H., Utiger R. D. Hyperthyroidism and excessive thyrotropin secretion. N Engl J Med. 1972 Aug 17;287(7):328–333. doi: 10.1056/NEJM197208172870704. [DOI] [PubMed] [Google Scholar]
  9. FURTH J., DENT J. N., BURNETT W. T., Jr, GADSDEN E. L. The mechanism of induction and the characteristics of pituitary tumors induced by thyroidectomy. J Clin Endocrinol Metab. 1955 Jan;15(1):81–97. doi: 10.1210/jcem-15-1-81. [DOI] [PubMed] [Google Scholar]
  10. Furth J., Moy P., Hershman J. M., Ueda G. Thyrotropic tumor syndrome. A multiglandular disease induced by sustained deficiency of thyroid hormones. Arch Pathol. 1973 Oct;96(4):217–226. [PubMed] [Google Scholar]
  11. Gershengorn M. C., Weintraub B. D. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH". J Clin Invest. 1975 Sep;56(3):633–642. doi: 10.1172/JCI108133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Horn K., Erhardt F., Fahlbusch R., Pickardt C. R., Werder K. V., Scriba P. C. Recurrent goiter, hyperthyroidism, galactorrhea and amenorrhea due to a thyrotropin and prolactin-producing pituitary tumor. J Clin Endocrinol Metab. 1976 Jul;43(1):137–143. doi: 10.1210/jcem-43-1-137. [DOI] [PubMed] [Google Scholar]
  13. Kaplan M. M., Swartz S. L., Larsen P. R. Partial peripheral resistance to thyroid hormone. Am J Med. 1981 May;70(5):1115–1121. doi: 10.1016/0002-9343(81)90885-8. [DOI] [PubMed] [Google Scholar]
  14. Kourides I. A., Ridgway E. C., Weintraub B. D., Bigos S. T., Gershengorn M. C., Maloof F. Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identify patients with pituitary tumors. J Clin Endocrinol Metab. 1977 Sep;45(3):534–543. doi: 10.1210/jcem-45-3-534. [DOI] [PubMed] [Google Scholar]
  15. Kourides I. A., Weintraub B. D., Ridgway E. C., Maloof F. Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders. J Clin Endocrinol Metab. 1975 May;40(5):872–885. doi: 10.1210/jcem-40-5-872. [DOI] [PubMed] [Google Scholar]
  16. Lamberg B. A. Congenital euthyroid goitre and partial peripheral resistance to thyroid hormones. Lancet. 1973 Apr 21;1(7808):854–857. doi: 10.1016/s0140-6736(73)91421-9. [DOI] [PubMed] [Google Scholar]
  17. LeRoith D., Liel Y., Sack J., Livshin Y., Laufer N., Schenker J., Spitz I. M. The TSH response to TRH is exaggerated in primary testicular failure and normal in the male castrate. Acta Endocrinol (Copenh) 1981 May;97(1):103–108. doi: 10.1530/acta.0.0970103. [DOI] [PubMed] [Google Scholar]
  18. Linde R., Alexander N., Island D. P., Rabin D. Familial insensitivity of the pituitary and periphery to thyroid hormone: a case report in two generations and a review of the literature. Metabolism. 1982 May;31(5):510–513. doi: 10.1016/0026-0495(82)90243-8. [DOI] [PubMed] [Google Scholar]
  19. Mihailovic V., Feller M. S., Kourides I. A., Utiger R. D. Hyperthyroidism due to excess thyrotropin secretion: follow-up studies. J Clin Endocrinol Metab. 1980 Jun;50(6):1135–1138. doi: 10.1210/jcem-50-6-1135. [DOI] [PubMed] [Google Scholar]
  20. Re R. N., Kourides I. A., Ridgway E. C., Weintraub B. D., Maloof F. The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab. 1976 Aug;43(2):338–346. doi: 10.1210/jcem-43-2-338. [DOI] [PubMed] [Google Scholar]
  21. Refetoff S., DeWind L. T., DeGroot L. J. Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab. 1967 Feb;27(2):279–294. doi: 10.1210/jcem-27-2-279. [DOI] [PubMed] [Google Scholar]
  22. Reschini E., Giustina G., Cantalamessa Lperacchi M. Hyperthyroidism with elevated plasma TSH levels and pituitary tumor: study with somatostatin. J Clin Endocrinol Metab. 1976 Oct;43(4):924–927. doi: 10.1210/jcem-43-4-924. [DOI] [PubMed] [Google Scholar]
  23. Rösler A., Litvin Y., Hage C., Gross J., Cerasi E. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine. J Clin Endocrinol Metab. 1982 Jan;54(1):76–82. doi: 10.1210/jcem-54-1-76. [DOI] [PubMed] [Google Scholar]
  24. Samaan N. A., Osborne B. M., Mackay B., Leavens M. E., Duello T. M., Halmi N. S. Endocrine and morphologic studies of pituitary adenomas secondary to primary hypothyroidism. J Clin Endocrinol Metab. 1977 Nov;45(5):903–911. doi: 10.1210/jcem-45-5-903. [DOI] [PubMed] [Google Scholar]
  25. Sato T., Saida K., Suzuki Y., Takata I., Ishiguro K. A case of the syndrome of inappropriate secretion of TSH. Endocrinol Jpn. 1979 Oct;26(5):623–630. doi: 10.1507/endocrj1954.26.623. [DOI] [PubMed] [Google Scholar]
  26. Shenkman L., Mitsuma T., Hollander C. S. Modulation of pituitary responsiveness to thyrotropin-releasing hormone by triiodothyronine. J Clin Invest. 1973 Jan;52(1):205–209. doi: 10.1172/JCI107166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Smallridge R. C., Wartofsky L., Dimond R. C. Inappropriate secretion of thyrotropin: discordance between the suppressive effects of corticosteroids and thyroid hormone. J Clin Endocrinol Metab. 1979 Apr;48(4):700–705. doi: 10.1210/jcem-48-4-700. [DOI] [PubMed] [Google Scholar]
  28. Snyder P. J., Jacobs L. S., Utiger R. D., Daughaday W. H. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. J Clin Invest. 1973 Sep;52(9):2324–2329. doi: 10.1172/JCI107421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Spitz I. M., LeRoith D., Livshin Y., Zylber-Haran E., Trestian S., Laufer N., Ron M., Palti Z., Schenker J. Exaggerated prolactin response to thyrotropin-releasing hormone and metoclopramide in primary testicular failure. Fertil Steril. 1980 Dec;34(6):573–580. doi: 10.1016/s0015-0282(16)45198-8. [DOI] [PubMed] [Google Scholar]
  30. Spitz I., Gonen B., Rabinowitz D. Agnogenic and stimulus-initiated growth hormone release in man. A reappraisal and a multiple pool model of hormonal release. Johns Hopkins Med J. 1972 Aug;131(2):149–159. [PubMed] [Google Scholar]
  31. Staub J. J., Conti A., Huber P., Martens M., Ackermann F., Müller-Brand J., Kofler C. Sexhormonbindendes Globulin (SHBG), ein neuer metabolischer In-vitro-Test der Schilddrüsenfunktion. Schweiz Med Wochenschr. 1978 Dec 2;108(48):1909–1911. [PubMed] [Google Scholar]
  32. Tamagna E. I., Carlson H. E., Hershman J. M., Reed A. W. Pituitary and peripheral resistance to thyroid hormone. Clin Endocrinol (Oxf) 1979 May;10(5):431–441. doi: 10.1111/j.1365-2265.1979.tb02099.x. [DOI] [PubMed] [Google Scholar]
  33. Tolis G., Bird C., Bertrand G., McKenzie J. M., Ezrin C. Pituitary hyperthyroidism. Case report and review of the literature. Am J Med. 1978 Jan;64(1):177–181. doi: 10.1016/0002-9343(78)90202-4. [DOI] [PubMed] [Google Scholar]
  34. Vagenakis A. G., Dole K., Braverman L. E. Pituitary enlargement, pituitary failure, and primary hypothyroidism. Ann Intern Med. 1976 Aug;85(2):195–198. doi: 10.7326/0003-4819-85-2-195. [DOI] [PubMed] [Google Scholar]
  35. Waldhäusl W., Bratusch-Marrain P., Nowotny P., Büchler M., Forssmann W. G., Lujf A., Schuster H. Secondary hyperthyroidism due to thyrotropin hypersecretion: study of pituitary tumor morphology and thyrotropin chemistry and release. J Clin Endocrinol Metab. 1979 Dec;49(6):879–887. doi: 10.1210/jcem-49-6-879. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES